Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03247283 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Metabolism Study in Healthy Male Participants
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03247283 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 9 participants.
The verdict
NCT03247283, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Phase 1 Phamacokinetic and metabolism study of BMS-986205 in healthy males
Interventions
- DRUG BMS-986205
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-07-19 |
| Est. Completion | 2017-10-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03247283
The ClinicalTrials.gov registry entry for NCT03247283 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BMS-986205 is the first listed.
NCT03247283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03247283 about?
NCT03247283 is a clinical study titled "Pharmacokinetics and Metabolism Study in Healthy Male Participants". Phase 1 Phamacokinetic and metabolism study of BMS-986205 in healthy males
What is the current status of trial NCT03247283?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2017-07-19. Estimated completion is 2017-10-15.
What interventions are being tested in trial NCT03247283?
The interventions under investigation include: BMS-986205 (DRUG).
Who is sponsoring clinical trial NCT03247283?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.